• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症间日疟:印度西南部一家三级医疗中心的前瞻性探索。

Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India.

作者信息

Kumar Rishikesh, Saravu Kavitha

机构信息

a Department of Medicine, Kasturba Medical College , Manipal University , Manipal , India.

b Manipal McGill Center for Infectious Diseases (MAC-ID) , Manipal University , Manipal , India.

出版信息

Pathog Glob Health. 2017 May;111(3):148-160. doi: 10.1080/20477724.2017.1309342. Epub 2017 Apr 3.

DOI:10.1080/20477724.2017.1309342
PMID:28367735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5445641/
Abstract

Plasmodium vivax is recognized to cause severe malaria and mortality. We aimed to determine the proportion of disease severity, the spectrum of complications, underlying non-infectious comorbidities and predictors of severity in monoinfection P. vivax malaria among adults at a tertiary healthcare centre in Southwestern India. A prospective cohort study was conducted among microscopically confirmed monoinfection P. vivax acute malaria patients aged, ≥18 years. Cases with pregnancy and concomitant febrile illnesses including mixed malaria were excluded. Cases were distinguished as either 'severe' or 'non-severe' P. vivax malaria as per the definitions laid by the World Health Organization. Of total 511 acute P. vivax cases studied, 23.9% (122/511) had severe malaria. The proportion of severity did not vary between microscopy alone and additional nPCR proved monoinfection P. vivax subgroups. There was no significant difference (p = 0.296) in the occurrence of non-infectious comorbidities among non-severe (9.0%, 35/389) and severe (12.3%, 15/122) vivax groups. Multiple complications despite early parasite clearance resulted in delayed casualty in two cases, indicating overall case fatality rate of 3/1000 cases. Age >40 years, rising respiratory rate, total bilirubin, serum creatinine and falling hemoglobin were the independent predictors of disease severity in this vivax malaria cohort. Total and direct bilirubin and serum urea had good discriminatory performance for severe vivax malaria. Total bilirubin should be considered as an important prognostic marker while managing P. vivax malaria. Patients with multiple complications must be treated cautiously as there may be delayed deterioration leading to mortality despite parasite clearance.

摘要

间日疟原虫被认为会导致严重疟疾和死亡。我们旨在确定印度西南部一家三级医疗中心成年单感染间日疟原虫疟疾患者中疾病严重程度的比例、并发症谱、潜在非感染性合并症以及严重程度的预测因素。对年龄≥18岁、经显微镜确诊为单感染间日疟原虫急性疟疾的患者进行了一项前瞻性队列研究。排除妊娠及伴有发热性疾病(包括混合疟疾)的病例。根据世界卫生组织制定的定义,病例被区分为“严重”或“非严重”间日疟原虫疟疾。在总共研究的511例急性间日疟原虫病例中,23.9%(122/511)患有严重疟疾。仅通过显微镜检查和经额外巢式聚合酶链反应(nPCR)证实的单感染间日疟原虫亚组之间,严重程度比例没有差异。在非严重(9.0%,35/389)和严重(12.3%,15/122)间日疟原虫组中,非感染性合并症的发生率没有显著差异(p = 0.296)。尽管寄生虫早期清除,但仍出现多种并发症,导致两例患者死亡延迟,表明总体病死率为3/1000例。年龄>40岁、呼吸频率升高、总胆红素、血清肌酐升高以及血红蛋白降低是该间日疟原虫疟疾队列中疾病严重程度的独立预测因素。总胆红素和直接胆红素以及血清尿素对严重间日疟原虫疟疾具有良好的鉴别性能。在管理间日疟原虫疟疾时,应将总胆红素视为重要的预后标志物。患有多种并发症的患者必须谨慎治疗,因为尽管寄生虫已清除,但可能会出现延迟恶化导致死亡。

相似文献

1
Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India.重症间日疟:印度西南部一家三级医疗中心的前瞻性探索。
Pathog Glob Health. 2017 May;111(3):148-160. doi: 10.1080/20477724.2017.1309342. Epub 2017 Apr 3.
2
Severity in Plasmodium vivax malaria claiming global vigilance and exploration--a tertiary care centre-based cohort study.间日疟原虫疟疾的严重程度需全球警惕并加以探究——一项基于三级医疗中心的队列研究
Malar J. 2014 Aug 8;13:304. doi: 10.1186/1475-2875-13-304.
3
A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.一项在马来西亚沙巴州进行的关于诺氏疟原虫、恶性疟原虫和间日疟原虫的前瞻性对比研究:来自诺氏疟原虫和间日疟原虫的严重疾病比例较高,但如果早期转诊和使用青蒿琥酯治疗则无死亡。
Clin Infect Dis. 2013 Feb;56(3):383-97. doi: 10.1093/cid/cis902. Epub 2012 Oct 19.
4
Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.重症间日疟原虫疟疾:来自印度西北部比卡内尔的系列病例报告。
Am J Trop Med Hyg. 2009 Feb;80(2):194-8.
5
Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.印度西南部一家三级护理医院对间日疟原虫疟疾成年患者队列采用氯喹-伯氨喹联合疗法的治疗评估
Malar J. 2015 Aug 11;14:310. doi: 10.1186/s12936-015-0824-y.
6
Clinical and epidemiological profiles of severe malaria in children from Delhi, India.印度德里儿童重症疟疾的临床和流行病学特征
J Health Popul Nutr. 2012 Mar;30(1):113-6. doi: 10.3329/jhpn.v30i1.11291.
7
Are respiratory complications of Plasmodium vivax malaria an underestimated problem?间日疟原虫疟疾的肺部并发症是否被低估了?
Malar J. 2017 Dec 22;16(1):495. doi: 10.1186/s12936-017-2143-y.
8
Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India.印度西南部一家三级医疗中心的恶性疟原虫和间日疟原虫患者的人口统计学和临床特征。
Malar J. 2016 Nov 25;15(1):569. doi: 10.1186/s12936-016-1619-5.
9
Clinical spectrum and predictors of severe Plasmodium vivax infections at a tertiary care center in North India.印度北部一家三级护理中心的严重间日疟原虫感染的临床谱和预测因素。
Drug Discov Ther. 2021 Jan 23;14(6):330-335. doi: 10.5582/ddt.2020.03110. Epub 2020 Dec 31.
10
Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India.过去两年间严重的间日疟趋势:来自印度德里一家三级护理中心的研究。
Ann Clin Microbiol Antimicrob. 2020 Oct 30;19(1):49. doi: 10.1186/s12941-020-00393-9.

引用本文的文献

1
Alteration of Platelet Count in Patients with Severe Non- Malaria: A Systematic Review and Meta-Analysis.重症非疟疾患者血小板计数的改变:一项系统评价与Meta分析
Biology (Basel). 2021 Dec 5;10(12):1275. doi: 10.3390/biology10121275.
2
Clinical and Lab profile of severe and uncomplicated malaria: A prospective study from Khuzdar Balochistan.重症与非重症疟疾的临床及实验室特征:来自俾路支省胡兹达尔的一项前瞻性研究
Pak J Med Sci. 2021 Nov-Dec;37(7):1918-1923. doi: 10.12669/pjms.37.7.4210.
3
Distribution pattern of amino acid mutations in chloroquine and antifolate drug resistance associated genes in complicated and uncomplicated Plasmodium vivax isolates from Chandigarh, North India.印度北部昌迪加尔地区复杂和不复杂间日疟原虫分离株中氯喹和抗叶酸药物耐药相关基因的氨基酸突变分布模式。
BMC Infect Dis. 2020 Sep 15;20(1):671. doi: 10.1186/s12879-020-05397-6.
4
New laboratory perspectives for evaluation of vivax malaria infected patients: a useful tool for infection monitoring.评估 vivax 疟疾病例的新实验室视角:监测感染的有用工具。
Braz J Infect Dis. 2020 Mar-Apr;24(2):120-129. doi: 10.1016/j.bjid.2020.04.001. Epub 2020 Apr 23.
5
Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax.天门冬氨酸氨基转移酶-血小板比值指数(APRI):一种用于诊断因间日疟原虫引起的重度疟疾高危患者的潜在标志物。
PLoS One. 2019 Nov 25;14(11):e0224877. doi: 10.1371/journal.pone.0224877. eCollection 2019.
6
Technical and Alarm signs for referral in adult patients with acute febrile illness: A study from a tertiary care hospital in North India.成年急性发热性疾病患者转诊的技术与警示标志:来自印度北部一家三级护理医院的研究
J Family Med Prim Care. 2018 Jul-Aug;7(4):832-835. doi: 10.4103/jfmpc.jfmpc_138_18.
7
A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.一项在印度南部比较两种 14 天伯氨喹根治方案疗效的随机对照临床试验。
Malar J. 2018 Sep 3;17(1):321. doi: 10.1186/s12936-018-2472-5.
8
Are respiratory complications of Plasmodium vivax malaria an underestimated problem?间日疟原虫疟疾的肺部并发症是否被低估了?
Malar J. 2017 Dec 22;16(1):495. doi: 10.1186/s12936-017-2143-y.

本文引用的文献

1
Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.印度西南部基层医疗中心成人间日疟原虫疟疾队列中氯喹-伯氨喹联合治疗方案的疗效评估
PLoS One. 2016 Jun 17;11(6):e0157666. doi: 10.1371/journal.pone.0157666. eCollection 2016.
2
Attractiveness of volatiles from different body parts to the malaria mosquito Anopheles coluzzii is affected by deodorant compounds.不同身体部位挥发物对疟蚊 Anopheles coluzzii 的吸引力受除臭剂化合物的影响。
Sci Rep. 2016 Jun 1;6:27141. doi: 10.1038/srep27141.
3
Clinical and epidemiological aspects of complicated malaria in Colombia, 2007-2013.2007 - 2013年哥伦比亚复杂疟疾的临床与流行病学特征
Malar J. 2016 May 10;15(1):269. doi: 10.1186/s12936-016-1323-5.
4
Polymorphisms in B Cell Co-Stimulatory Genes Are Associated with IgG Antibody Responses against Blood-Stage Proteins of Plasmodium vivax.B细胞共刺激基因多态性与间日疟原虫血液期蛋白的IgG抗体反应相关。
PLoS One. 2016 Feb 22;11(2):e0149581. doi: 10.1371/journal.pone.0149581. eCollection 2016.
5
Clinical manifestations and molecular mechanisms in the changing paradigm of vivax malaria in India.印度间日疟原虫疟疾变化模式中的临床表现及分子机制
Infect Genet Evol. 2016 Apr;39:317-324. doi: 10.1016/j.meegid.2016.02.014. Epub 2016 Feb 12.
6
Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.印度西南部一家三级护理医院对间日疟原虫疟疾成年患者队列采用氯喹-伯氨喹联合疗法的治疗评估
Malar J. 2015 Aug 11;14:310. doi: 10.1186/s12936-015-0824-y.
7
Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia.哥伦比亚疟疾传播率低且不稳定地区恶性疟原虫和间日疟原虫感染的临床特征
Malar J. 2015 Apr 11;14:154. doi: 10.1186/s12936-015-0678-3.
8
Surmised total leucocyte counts miscalculate the parasite index of Plasmodium vivax malaria patients of tertiary and primary care settings in South-Western India.推测的白细胞总数会错误计算印度西南部三级和初级保健机构中间日疟原虫疟疾患者的寄生虫指数。
Malar J. 2015 Apr 16;14:163. doi: 10.1186/s12936-015-0669-4.
9
Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.缅甸东北部间日疟原虫疟疾对氯喹和伯氨喹治疗的反应
Antimicrob Agents Chemother. 2015 Feb;59(2):1230-5. doi: 10.1128/AAC.04270-14. Epub 2014 Dec 15.
10
Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax.不同伯氨喹方案对间日疟原虫的抗复发疗效
Malar Res Treat. 2014;2014:347018. doi: 10.1155/2014/347018. Epub 2014 Sep 10.